Loading clinical trials...
Loading clinical trials...
To evaluate the efficacy and safety of LAS 34273 compared to placebo in patients with moderate to severe COPD during one year of treatment.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
AstraZeneca
NCT07307781 · Chronic Obstructive Pulmonary Disease (COPD)
NCT07509606 · Chronic Obstructive Pulmonary Disease (COPD), Whole Body Vibration
NCT07451977 · Chronic Respiratory Failure, Hypoxemia, and more
NCT07082738 · Chronic Obstructive Pulmonary Disease (COPD)
NCT07477600 · Chronic Obstructive Pulmonary Disease (COPD)
Almirall Investigational Sites#926
Jasper, Alabama
Almirall Investigational Sites#858
Ozark, Alabama
Almirall Investigational Sites#900
Phoenix, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions